Metabolism - Clinical and Experimental
Volume 44 , Pages 45-49 , October 1995

The role of growth hormone/insulin-like growth factors in adipocyte differentiation

  • Martin Wabitsch

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Martin Wabitsch, MD, Department of Pediatrics I, University of Ulm, D-89075 Ulm, Germany.
    • Department of Pediatrics I, University of Ulm, Ulm, Germany
    • Diabetes Research Institute, University of Duesseldorf, Duesseldorf, Germany
    • ,
  • Hans Hauner

      Affiliations

    • Department of Pediatrics I, University of Ulm, Ulm, Germany
    • Diabetes Research Institute, University of Duesseldorf, Duesseldorf, Germany
    • ,
  • Eberhard Heinze

      Affiliations

    • Department of Pediatrics I, University of Ulm, Ulm, Germany
    • Diabetes Research Institute, University of Duesseldorf, Duesseldorf, Germany
    • ,
  • Walter M. Teller

      Affiliations

    • Department of Pediatrics I, University of Ulm, Ulm, Germany
    • Diabetes Research Institute, University of Duesseldorf, Duesseldorf, Germany

References 

  1. Isaksson OGP, Eden S, Jansson JO. Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol. 1985;47:483–499
  2. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev. 1990;70:591–614
  3. Zapf J, Froesch ER, Humbel RE. The insulin-like growth factors (IGF) of human serum: Chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul. 1981;19:257–309
  4. Van Wyk JJ, Casella SJ, Hynes M, et al.  Indirect actions of growth hormone. In:  Underwood LE editors. Human Growth Hormone. ed 2. Progress and Challenges. New York, NY: Dekker; 1988;p. 25–61
  5. Froesch ER, Schmid CH, Zangger I, et al.  Effects of IGF/somatomedins on growth and differentiation of muscle and bone. J Anim Sci. 1986;63:57–75
  6. Elgin RG, Busby WH, Clemmons DR. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. In: ed 2. Proc Natl Acad Sci USA. 84:1987;p. 3254–3258
  7. Ritvos O, Ranta T, Jalkanen J, et al.  Insulin-like growth factor binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology. 1988;122:2150–2157
  8. Clemmons DR, Klibanski A, Underwood LE, et al.  Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab. 1981;53:1247–1251
  9. Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab. 1982;55:999–1002
  10. Davidsson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev. 1987;8:115–123
  11. Laron Z, Klinger B. Body fat in Laron syndrome patients: Effect of insulin-like growth factor I treatment. Horm Res. 1993;40:16–22
  12. Bonnet FP, Vanderschueren-Lodeweycks M, Eeckels R, et al.  Subcutaneous adipose tissue and lipids in blood in growth hormone deficiency before and after treatment with human growth hormone. Pediatr Res. 1974;8:800–805
  13. Skaggs SR, Crist DM. Exogenous human growth hormone reduces body fat in obese woman. Horm Res. 1991;35:19–24
  14. Eden S, Bengtsson B-A, Oscarsson J. Effects of growth hormone on body composition and metabolism. Acta Paediatr Scand. 1990;367:14–19
  15. Brook CGD. Evidence for a sensitive period in adipose cell replication in man. Lancet. 1972;2:624–627
  16. Knittle JM, Timmers K, Ginsberg-Fellner F, et al.  The growth of adipose tissue in children and adolescents. In: Cross-sectional and longitudinal studies of adipose cell number and size. ed 2. J Clin Invest. 63:1979;p. 239–246
  17. Hirsch J, Knittle JL. Cellularity of obese and nonobese human tissue. Fed Proc. 1970;29:1516–1521
  18. Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue. In: Adipose cell size and number in non-obese and obese patients. ed 2. J Clin Invest. 52:1973;p. 929–941
  19. Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin Endocrinol Metab. 1976;5:299–311
  20. Hauner H, Entenmann G, Wabitsch M, et al.  Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest. 1989;84:1663–1670
  21. Green H, Kehinde O. Sublines of mouse 3T3 cells that accumulate lipids. Cell. 1974;1:113–116
  22. Negrel R, Grimaldi P, Ailhaud G. Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones. In: ed 2. Proc Natl Acad Sci USA. 75:1978;p. 6045–6058
  23. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 1992;12:207–233
  24. Morikawa M, Nixon T, Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell. 1982;29:783–789
  25. Nixon T, Green H. Contribution of growth hormone to the adipogenic activity of serum. Endocrinology. 1984;114:527–532
  26. Hauner H, Löffler G. Adipogenic factors in human serum promote the adipose conversion of 3T3-L1 fibroblasts. Int J Obes. 1986;10:323–330
  27. Doglio A, Dani C, Grimaldi P, et al.  Growth hormone regulation of the expression of differentiation-dependent genes in preadipocyte Ob 1771 cells. Biochem J. 1986;238:123–129
  28. Green H, Morikawa M, Nixon T. A dual effector theory of growth-hormone action. Differentiation. 1985;29:195–198
  29. Corin RE, Guller SW, Wit K, et al.  Growth hormone and adipose differentiation: Growth hormone-induced antimitogenic state in 3T3-F442A preadipocytes. In: ed 2. Proc Natl Acad Sci USA. 87:1990;p. 7507–7511
  30. Guller S, Corin RE, Wu KY, et al.  Growth hormone-induced alteration of morphology and tubulin expression in 3T3 preadipose cells. Biochem Biophys Res Commun. 1989;163:895–901
  31. Guller S, Corin RE, Yuan-Wu K, et al.  Up-regulation of vinculin expression in 3T3 preadipose cell by growth hormone. Endocrinology. 1991;129:527–533
  32. Doglio A, Dani C, Grimaldi P, et al.  Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover. In: ed 2. Proc Natl Acad Sci USA. 86:1989;p. 1148–1152
  33. Smal J, De Meyts P. Sphingosine, an inhibitor of protein kinase C, suppresses the insulin-like effects of growth hormone in rat adipocytes. In: ed 2. Proc Natl Acad Sci USA. 86:1989;p. 4705–4709
  34. Doglio A, Dani C, Fredrikson G, et al.  Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation. EMBO J. 1987;13:4011–4016
  35. Zezulak KM, Green H. The generation of insulin-like growth factor-I-sensitive cells by growth hormone action. Science. 1986;233:551–553
  36. Hausman GJ, Martin RJ. The influence of human growth hormone on preadipocyte development in serum-supplemented and serum-free cultures of stromal-vascular cells from pig adipose tissue. Domest Anim Endocrinol. 1989;6:331–337
  37. Wabitsch M; Heinze E; Hauner H: Biological effects of human growth hormone on rat adipocyte precursor cells and newly differentiated adipocytes in primary culture. Metabolism (in press)
  38. Smith PJ, Wise LS, Berkowitz R, et al.  Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 1988;263:9402–9408
  39. Schmidt W, Pöll-Jordan G, Löffler G. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP. J Biol Chem. 1990;265:15489–15495
  40. Deslex S, Negrel R, Ailhaud G. Development of a chemically defined, serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res. 1987;168:15–30
  41. Ramsay TG, White ME, Wolverton CK. Insulin-like growth factor-I induction of differentiation of porcine preadipocytes. J Anim Sci. 1989;67:2452–2459
  42. Nougues J, Reyne Y, Barenton B, et al.  Differentiation of adipocyte precursors in a serum-free medium is influenced by glucocorticoids and endogenously produced insulin-like growth factor-I. Int J Obes. 1993;17:159–167
  43. Peter MA, Winterhalter KH, Böni-Schnetzler M, et al.  Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology. 1993;133:2624–2631
  44. Wolverton CK, Azain MJ, Duffy JY, et al.  Influence of somatotropin on lipid metabolism and IGF gene expression in porcine adipose tissue. Am J Physiol. 1992;263:E637–E645
  45. Gaskin HR, Kim JW, Wright JT, et al.  Regulation of insulin-like growth factor-I ribonucleic acid expression, polypeptide secretion, and binding protein activity by growth hormone in porcine preadipocyte cultures. Endocrinology. 1990;126:622–630
  46. Kern PA, Svoboda ME, Eckel RH, et al.  Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue. Diabetes. 1989;38:710–717
  47. Rabinowitz D, Klassen GA, Zierler KL. Effects of human growth hormone on muscle and adipose tissue metabolism of the forearm of man. J Clin Invest. 1965;44:51–55
  48. Rizza RA, Mandarino JL, Gerich JE. Effects of growth hormone on insulin action in man: Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 1982;31:663–669
  49. Wabitsch M, Hauner H, Heinze E, et al.  In vitro effects of growth hormone in adipose tissue. Acta Paediatr. 1994;406:48–53
  50. Schwartz J, Carter-Su C. Effects of growth hormone on glucose metabolism and glucose transport in 3T3-F442A cells: Dependence on cell differentiation. Endocrinology. 1988;122:2247–2256
  51. Tai P, Liao JF, Chen EH, et al.  Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells. J Biol Chem. 1990;265:21828–21834
  52. Shimizu M, Torti F, Roth RA. Characterization of the insulin and insulin-like growth factor receptors and responsivity of a fibroblast/adipocyte cell line before and after differentiation. Biochem Biophys Res Commun. 1986;137:552–558
  53. Schwartz J, Goodman HM. Comparison of the delayed actions of growth hormone and somatomedin on adipose tissue metabolism. Endocrinology. 1976;98:730–737
  54. Lewis KJ, Molan PC, Bass JJ, et al.  The lipolytic activity of low concentrations of insulin-like growth factors in ovine adipose tissue. Endocrinology. 1988;122:2554–2557
  55. Schoenle EJ, Zenobi PD, Torresani T, et al.  Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycemia in patients with extreme insulin resistance. Diabetologia. 1991;34:675–679
  56. Zenobi PD, Jaeggi-Groisman SE, Riesen WF, et al.  Insulinlike growth factor I improves glucose and lipid metabolism in type 2 diabetes mellitus. J Clin Invest. 1992;90:2234–2241
  57. Kuzuya H, Matsuura N, Sakamoto M, et al.  Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes. 1993;42:696–705
  58. Usala AL, Madigan T, Burguera B, et al.  High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes mellitus. J Clin Endocrinol Metab. 1994;79:435–440

PII: 0026-0495(95)90220-1

Metabolism - Clinical and Experimental
Volume 44 , Pages 45-49 , October 1995

Article Tools